ArriVent BioPharma, Inc. (AVBP)

NASDAQ: AVBP · IEX Real-Time Price · USD

18.77

-0.43 (-2.24%)

At close: Jul 19, 2024, 12:00 AM

18.90

+0.13 (0.69%)

Pre-market: Jul 22, 2024, 8:00 AM EDT

ArriVent BioPharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Net Income	-	-69.33	-36.91
Share-Based Compensation	-	0.9	0.42
Other Operating Activities	-	12.6	-7.15
Operating Cash Flow	-	-55.84	-43.63
Share Issuance / Repurchase	-	0.35	0.02
Other Financing Activities	-	42.51	169.71
Financing Cash Flow	-	42.86	169.72
Net Cash Flow	-	-12.98	126.09
Free Cash Flow	-	-55.84	-43.63
Free Cash Flow Per Share	-	-26.08	-34.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).